Search clinical trials for: low molecular weight heparin.

Total 3494 results

Ottawa Hospital Research Institute

Completed

Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal Cancer (PERIOP-01)

Adenocarcinoma of the Colon

Canada, France, Belgium
Pfizer

Completed

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Venous Thromboembolism

United States, Norway, Russian Federation, Slovenia, Spain
Groupe Hospitalier Pitie-Salpetriere
Assistance Publique Hopitaux De Marseille

Completed

Venous Thromboprophylaxis in Bariatric Surgery (OBSUD)

Obesity
Ribe County Hospital
LEO Pharma; Coloplast A/S

Terminated

MesoHep II: Intraperitoneal Low Molecular Weight Heparin in Peritoneal Dialysis

Inflammation | Peritoneal Dialysis | Nutrition

Denmark
Ontario Clinical Oncology Group (OCOG)
Pfizer

Completed

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Venous Thromboembolism | Brain Tumors

United States, Canada, Australia, Italy
Nanfang Hospital of Southern Medical University

Unknown

Pregnancy Outcome of Women Using Low Molecular Weight Heparin Before Frozen-thawed Embryo Transfer

Infertility

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Dalteparin in Preventing DVT in Participants With Cancer

Soft Tissue Sarcoma | Lymphoma | Plasma Cell Myeloma | Bone Sarcoma | Femur Fracture | Metastatic Neoplasm | Pathologic Fracture

United States
University Medical Centre Ljubljana

Completed

Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis (REVETR)

Superficial Thrombophlebitis

Slovenia
Medical University of Vienna

Terminated

Thromboprophylaxis in Critically Ill Patients

Venous Thromboembolism

Austria
Iladevi Cataract and IOL Research Center

Completed

Set up for in-Vivo Measurement of Dynamic Intraocular Pressure (IOP)

Intraocular Pressure

India
Mount Sinai Hospital, Canada
Pfizer; Canadian Institutes of Health Research (CIHR)

Terminated

Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT (HepASA)

Recurrent Pregnancy Loss | Antiphospholipid Antibody Syndrome

Canada
Aalborg University Hospital
Aalborg University

Completed

Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities

Deep Venous Thrombosis

Denmark
Loewenstein Hospital
Meir Medical Center

Unknown

LMWH-VTE Prophylaxis for Survivors of Acute Ischemic Stroke- Assessment of Standard Dosing Regimen

Stroke

Israel
Mohamed Sayed Mohamed Abbas

Completed

Anti-Xa Assay Correlation to the Efficacy and Safety of Enoxaparin in the Treatment of Pulmonary Embolism

Anti-Xa Assay in Pulmonary Embolism
University of Calgary
LEO Pharma

Completed

Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing

Venous Thromboembolism

Canada
Medical College of Wisconsin
Ohio State University; Versiti

Completed

Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis

Neoplasms | Venous Thrombosis

United States
Kantonsspital Winterthur KSW

Completed

Influence of Acetylsalicylic Acid and Low Molecular Weight Heparins on the Incidence of Renal Hematoma of Shockwave Lithotripsy

Urolithiasis | Renal Hematoma

Switzerland
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; National Cancer Institute, France

Terminated

Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) (PROVE)

Venous Thromboembolism | Lung Neoplasm

France
Lawson Health Research Institute
Pfizer; Canadian Institutes of Health Research (CIHR)

Unknown

PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.

Stroke

India, Canada
Maisonneuve-Rosemont Hospital

Completed

Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses (STRIP)

Renal Insufficiency, Chronic | Deep Venous Thrombosis, Protection Against

Canada
University of Vermont
National Cancer Institute (NCI)

Unknown

Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery

Kidney Cancer

United States
University of Calgary
Canadian Institutes of Health Research (CIHR); LEO Pharma; Dupont Applied Biosciences

Completed

Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)

Thrombosis | Venous Thrombosis | Thromboembolism

Canada
M.D. Anderson Cancer Center
Eisai Inc.

Completed

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

Pancreatic Cancer | Venous Thromboembolism

United States
Pfizer

Completed

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Cancer

United States, Canada, Spain, Austria, Netherlands
University of Florence

Terminated

LMWH to Prevent Preeclampsia and Fetal Growth Restriction

Preeclampsia
HaEmek Medical Center, Israel

Completed

A Prospective Study to Examine the Need to Adjust the Dose of Apixaban When Used in Atrial Fibrillation and Obesity

Obesity | Anticoagulant | Apixaban

Israel
Southeast University, China

Unknown

Anti-Xa Levels in Critically Ill Patients Receiving Low-molecular-weight Heparin for Thromboprophylaxis in China

Critically Ill | Anti-Xa

China
Lawson Health Research Institute
Pfizer

Completed

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

Embolism and Thrombosis

Canada
Organon and Co

Completed

Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)

Acute Coronary Syndrome
Sunnybrook Health Sciences Centre
Canadian Institutes of Health Research (CIHR); Sunnybrook Research Institute

Recruiting

PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) (PROTEST)

Traumatic Brain Injury

Canada
Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)

Atrial Fibrillation | Arterial Thromboembolic Events

United States
Thomas Decker Christensen

Completed

Coagulation Profile in Patients Undergoing Video Assisted Thorascopic Surgery (VATS) for Lung Cancer (COPPVATS)

Lung Cancer

Denmark
King Saud University
King AbdulAziz City for Science and Technology

Unknown

Venous Thromboembolism Prophylaxis Post Cesarean Section (PROCS)

Bleeding | Venous Thromboembolism

Saudi Arabia
Anthos Therapeutics, Inc.
Itreas

Recruiting

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE (MAGNOLIA)

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis

Austria, United States, Taiwan, Australia, Spain, Korea, Republic of, Italy, Hungary, France, Netherlands, Canada, Latvia, Germany, United Kingdom, Norway, Sweden, Ireland, Czechia, Switzerland
University Hospital of Patras

Recruiting

Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients (INTERACT)

Covid19 | Hospitalization

Greece
M.D. Anderson Cancer Center
Brookdale University Hospital Medical Center; Josephine Ford Cancer Center

Terminated

Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients

Neoplasms | Deep Vein Thrombosis

United States
University of Southern California
Celgene Corporation

Terminated

Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer

Cancer | Venous Thromboembolism

United States
Duke University
Eisai Limited

Completed

Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo

Sickle Cell Disease | Vaso-occlusive Crisis

United States
University of Calgary
Canadian Institutes of Health Research (CIHR); LEO Pharma; Dupont Applied Biosciences

Completed

Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin

Thrombosis | Venous Thrombosis | Thromboembolism

Canada
Hospices Civils de Lyon

Not yet recruiting

Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. AXAES (Anti Xa vs ACT-LR in Endovascular Surgery) (AXAES)

Thrombosis | Aortic Diseases | Arterial Disease

France
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
St. Joseph's Healthcare Hamilton
LEO Pharma; Heart and Stroke Foundation of Ontario

Terminated

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

Venous Thrombosis | Pulmonary Embolism

Canada
Ottawa Hospital Research Institute
LEO Pharma

Completed

Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer (PERI-OP)

Cancer | Deep Vein Thrombosis | Pulmonary Embolism

Canada
McMaster University

Completed

Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery

Lung Neoplasms | Venous Thromboembolism | Pulmonary Embolism

Canada
Martina Hansen's Hospital
Oslo University Hospital

Completed

Preoperative Versus Postoperative Start With Thromboprophylaxis in THA (Total Hip Arthroplasty)

Infection | Arthritis of the Hip | Transfusion Related Complications | Wound Discharge

Norway
Velindre NHS Trust

Unknown

Dalteparin in Preventing Blood Clots in Patients With Lung Cancer

Lung Cancer | Thromboembolism

United Kingdom
Bayer
Janssen Research & Development, LLC

Completed

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

Treatment of Venous Thromboembolism in Cancer Patients

Sweden
Fundación de investigación HM
Syntax for Science, S.L

Terminated

Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19

Covid-19

Spain
LEO Pharma

Completed

Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE) (PREDICARE)

Venous Thromboembolism

France
University of Aarhus
Aarhus University Hospital; LEO Pharma

Completed

Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight? (IUGR)

Fetal Growth Retardation

Denmark

Search clinical trials for: low molecular weight heparin.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations